Evidence map›Paper›PMID 32133998›Full record

ArticleActa crystallographica. Section F, Structural biology communications2020

Structure determination of the human TRPV1 ankyrin-repeat domain under nonreducing conditions.

Miki Tanaka, Kaori Hayakawa, Nozomi Ogawa, Tatsuki Kurokawa, Kenichi Kitanishi, Kenji Ite, Toshitaka Matsui, Yasuo Mori, Masaki Unno

Open access · greenAbstract read
In one paragraph

Article in Acta crystallographica. Section F, Structural biology communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Journal of Zhejiang University. Science. B · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Miki TanakaGraduate School of Science and Engineering, Ibaraki University, Hitachi, Ibaraki 316-8511, Japan.
Kaori HayakawaGraduate School of Science and Engineering, Ibaraki University, Hitachi, Ibaraki 316-8511, Japan.
Nozomi OgawaGraduate School of Engineering, Kyoto University, Kyoto, Kyoto 615-8510, Japan.
Tatsuki KurokawaGraduate School of Engineering, Kyoto University, Kyoto, Kyoto 615-8510, Japan.
Kenichi KitanishiGraduate School of Science and Engineering, Ibaraki University, Hitachi, Ibaraki 316-8511, Japan.
Kenji IteGraduate School of Science and Engineering, Ibaraki University, Hitachi, Ibaraki 316-8511, Japan.
Toshitaka MatsuiInstitute of Multidisciplinary Research for Advanced Materials, Tohoku University, Sendai, Miyagi 980-8577, Japan.
Yasuo MoriGraduate School of Engineering, Kyoto University, Kyoto, Kyoto 615-8510, Japan.
Masaki UnnoGraduate School of Science and Engineering, Ibaraki University, Hitachi, Ibaraki 316-8511, Japan.
Ibaraki University · JPHitachi (Japan) · JPKyoto University · JPOita University · JPTohoku University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

TRPV1, a member of the transient receptor potential (TRP) channels family, has been found to be involved in redox sensing. The crystal structure of the human TRPV1 ankyrin-repeat domain (TRPV1-ARD) was determined at 4.5 Å resolution under nonreducing conditions. This is the first report of the crystal structure of a ligand-free form of TRPV1-ARD and in particular of the human homologue. The structure showed a unique conformation in finger loop 3 near Cys258, which is most likely to be involved in inter-subunit disulfide-bond formation. Also, in human TRPV1-ARD it was possible for solvent to access Cys258. This structural feature might be related to the high sensitivity of human TRPV1 to oxidants. ESI-MS revealed that Cys258 did not form an S-OH functionality even under nonreducing conditions.

Indexed as

Ankyrin RepeatAnkyrinsCrystallizationHumansProtein Structure, SecondaryTRPV Cation ChannelsAnkyrinsTRPV1 protein, humanTRPV Cation Channelsakyrin-repeat domainhumannonreducing conditionsTRPV1

Identifiers

PMID32133998
PMCPMC7057350
OpenAlexW3010089835

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.